# Quantapore

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/quantapore

- Industry: Biopolymers
- Headquarters: Menlo Park, US
- Website: www.quantapore.com
- Latest round: Series C (Sep 27, 2016)
- Investors on record: 1

## About

Quantapore Inc. engineers advanced analytical platforms utilizing nanopore technology for direct single-molecule analysis, significantly enhancing capabilities in proteomics and genomics research.Founded in 2009 and headquartered in Menlo Park, US, Quantapore Inc. specializes in innovative protein analysis solutions. The company has secured a total of USD 15.55 mn in funding, with its most recent investment occurring on June 25, 2018, led by Northern Light Venture Capital. The firm has completed 4 deals to date. Christian Dennstedt is the founder, while Martin Huber serves as the CEO.Quantapore specializes in developing advanced analytical platforms that utilize single-molecule, solid-state nanopore technology. Their core offerings focus on creating massively parallel, direct single-molecule protein analytical tools aimed at overcoming limitations faced by researchers in the fields of proteomics and genomics. These innovative solutions facilitate higher throughput and greater accuracy in protein analysis, ultimately enhancing human health outcomes. Quantapore's target customers include academic research institutions, biotechnology companies, and pharmaceutical firms engaged in protein research and development, marketed primarily in North America, Europe, and Asia-Pacific regions.Quantapore generates revenue through direct sales of its proprietary analytical tools and platforms to research institutions and commercial partners, engaging in B2B transactions for streamlined purchases. Revenue derives from one-time sales of equipment and ongoing service agreements for technical support and software updates. The company also explores partnerships integrating subscription models for its software, allowing for a comprehensive offering that includes both initial product sales and recurring revenue from support and services.In July 2018, Quantapore Inc. raised USD 15.55 mn in venture funding to support future initiatives. The company plans to design and launch new products that enhance their analytical offerings, aiming for expansion into European and Asia-Pacific markets by 2025. Recent funding will be utilized for product development and increasing market penetration.

## Funding rounds

- Series C, Sep 27, 2016 — Helix China BioPharma

## Investors

- Helix China BioPharma (https://capitalatlas.ai/funds/helix-china-biopharma) — Series C